
Effect of Topical Diphenhydramine on the Laryngeal Chemoreflex
Holly C. Boyer, MD;
Daniel H. Downs, MD;
George S. Goding, Jr, MD;
Kerri J. Pernell, MS
Arch Otolaryngol Head Neck Surg. 1996;122(10):1112-1116.
Abstract
Objective To study diphenhydramine nebulization as a clinically applicable method for blunting laryngeal chemoreflex (LCR)-associated apnea.
Intervention Fourteen piglets aged 15 to 18 days were studied. In 7 piglets, diphenhydramine hydrochloride (5.0 mg/kg) was nebulized onto the laryngeal mucosa after a baseline response was obtained.
Results After a 10-minute waiting period, the mean±SD LCR-induced apnea duration decreased from 29± 13 seconds in the control animals to 15±5 seconds in the treated group (P=.02, 1-factor analysis of variance). After 1 hour, no treatment effect was seen.
Conclusions Nebulization of diphenhydramine can effectively reduce LCR-induced apnea for a short time. Nebulization of longer-acting agents may provide an effective prophylaxis of LCR-induced apnea.
Arch Otolaryngol Head Neck Surg. 1996;122:1112-1116
Author Affiliations
From the University of Minnesota and Hennepin County Medical Center, Minneapolis.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|